Gallant Ocean International, Inc. Xiaogang Plant
FDA import alert and refusal historyKaohsiung, TaiwanFEI 3006313857
Recorded by FDA as GALLANT OCEAN INTERNATIONAL, INC. XIAOGANG PLANT
As of October 26, 2026, Gallant Ocean International, Inc. Xiaogang Plant (KAOHSIUNG, Taiwan) is on the red list of FDA Import Alert 16-81 (Seafood products: Salmonella) for barramundi; lates calcarifer; koral; asian seabass, published by FDA on May 19, 2023, and has 8 FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 16-81 · red list
- Last import refusal
- Barramundi · SALMONELLA
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Gallant Ocean International, Inc. Xiaogang Plant
9 records, newest first. Each line links to the FDA page it came from.
2025
- Import refusalRefused, BarramundiSALMONELLAEntry GL5-5444478-3Source
2023
- Import refusalSource
Refused, 2 lines in one entry: BarramundiSALMONELLAEntry AQZ-0558840-8Show 2 linesHide lines
- Refused, BarramundiSALMONELLAEntry AQZ-0558840-8Source
- Refused, BarramundiSALMONELLAEntry AQZ-0558840-8Source
- Import refusalRefused, BarramundiSALMONELLAEntry KM6-3596453-9Source
- Import alert listingListed on Import Alert 16-81red listBarramundi; Lates calcarifer; Koral; Asian SeabassSource
2021
- Import refusalSource
Refused, 2 lines in one entry: Tilapia, aquaculture harvested fishery/seafood productsVETDRUGRESEntry GL5-5282128-9Show 2 linesHide lines
- Refused, Tilapia, aquaculture harvested fishery/seafood productsVETDRUGRESEntry GL5-5282128-9Source
- Refused, Tilapia, aquaculture harvested fishery/seafood productsVETDRUGRESEntry GL5-5282128-9Source
2019
- Import refusalRefused, TilapiaSALMONELLAEntry EBH-0083281-9Source
2017
- Import refusalRefused, Tilapia, aquaculture harvested fishery/seafood productsSALMONELLAEntry KM6-3509366-9Source
Refusal charges, in plain English
- SALMONELLA6 refused lines
Salmonella
The product appeared to contain Salmonella, which the law treats as a poisonous and deleterious substance that may make food injurious to health.
- VETDRUGRES2 refused lines
Animal drug residue
The product appeared to contain a new animal drug, or a conversion product of one, that is unsafe within the meaning of section 512 of the FD&C Act.
Questions about Gallant Ocean International, Inc. Xiaogang Plant
- Is Gallant Ocean International, Inc. Xiaogang Plant on an FDA import alert?
- Yes. As of October 26, 2026, Gallant Ocean International, Inc. Xiaogang Plant is on the red list of FDA Import Alert 16-81, “Seafood products: Salmonella”, for barramundi; lates calcarifer; koral; asian seabass; FDA published the listing on May 19, 2023.
- Has FDA refused shipments from Gallant Ocean International, Inc. Xiaogang Plant?
- Yes. FDA refused 8 shipment lines from Gallant Ocean International, Inc. Xiaogang Plant between December 5, 2017 and November 25, 2025. The most recent, on November 25, 2025, was barramundi, charged as SALMONELLA (salmonella).
- Why did FDA refuse Gallant Ocean International, Inc. Xiaogang Plant's shipments?
- The most frequent charges are SALMONELLA (salmonella, 6 lines) and VETDRUGRES (animal drug residue, 2 lines).
- What is Gallant Ocean International, Inc. Xiaogang Plant's FEI number?
- Gallant Ocean International, Inc. Xiaogang Plant's FDA Establishment Identifier (FEI) is 3006313857.
- Can shipments from Gallant Ocean International, Inc. Xiaogang Plant still enter the U.S.?
- Shipments of barramundi; lates calcarifer; koral; asian seabass from Gallant Ocean International, Inc. Xiaogang Plant can be detained without physical examination under Import Alert 16-81; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Gallant Ocean International, Inc. Xiaogang Plant?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.